AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
International Flavors & Fragrances
IFF
|
+$220M |
| 2 |
RTX Corp
RTX
|
+$218M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$177M |
| 4 |
PNC Financial Services
PNC
|
+$168M |
| 5 |
Medtronic
MDT
|
+$157M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$319M |
| 2 |
Apple
AAPL
|
+$209M |
| 3 |
Booking.com
BKNG
|
+$201M |
| 4 |
Starbucks
SBUX
|
+$153M |
| 5 |
Gilead Sciences
GILD
|
+$147M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.43% |
| 2 | Financials | 15.58% |
| 3 | Healthcare | 14.47% |
| 4 | Consumer Discretionary | 11.29% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Nabors Industries
NBR
$1.12B
| $1.12M | ﹤0.01% |
12,004
-301
| -2% | -$33.9K |
|
|
SJR
2202
DELISTED
Shaw Communications Inc.
SJR
| $1.12M | ﹤0.01% |
56,744
-904
| -2% | -$17.8K |
|
|
EPZM
2203
DELISTED
Epizyme, Inc
EPZM
| $1.11M | ﹤0.01% |
107,900
| – | – |
|
|
UBOH
2204
DELISTED
United Bancshares Inc/OH
UBOH
| $1.11M | ﹤0.01% |
55,603
-3,839
| -6% | -$79.5K |
|
2205
Cass Information Systems
CASS
$720M
| $1.1M | ﹤0.01% |
20,466
| – | – |
|
|
BFS
2206
Saul Centers
BFS
$870M
| $1.1M | ﹤0.01% |
20,191
-2,200
| -10% | -$117K |
|
|
TUP
2207
DELISTED
Tupperware Brands Corporation
TUP
| $1.1M | ﹤0.01% |
69,040
-51,181
| -43% | -$790K |
|
2208
Columbia Financial
CLBK
$1.14B
| $1.09M | ﹤0.01% |
69,300
| – | – |
|
2209
ProPetro Holding
PUMP
$1.31B
| $1.09M | ﹤0.01% |
120,178
-109,770
| -48% | -$1.52M |
|
2210
Shutterstock
SSTK
$220M
| $1.09M | ﹤0.01% |
30,228
-2,880
| -9% | -$106K |
|
|
CYBR
2211
DELISTED
CyberArk
CYBR
| $1.09M | ﹤0.01% |
10,905
-427
| -4% | -$51.5K |
|
2212
Denali Therapeutics
DNLI
$3.82B
| $1.09M | ﹤0.01% |
71,000
| – | – |
|
|
NFBK
2213
DELISTED
Northfield Bancorp
NFBK
| $1.09M | ﹤0.01% |
67,600
-9,557
| -12% | -$150K |
|
2214
Kelly Services Class A
KELYA
$560M
| $1.08M | ﹤0.01% |
44,774
-4,880
| -10% | -$127K |
|
2215
CytomX Therapeutics
CTMX
$701M
| $1.08M | ﹤0.01% |
146,637
-21,350
| -13% | -$211K |
|
|
GTHX
2216
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $1.08M | ﹤0.01% |
47,500
| – | – |
|
2217
Coeur Mining
CDE
$15.4B
| $1.08M | ﹤0.01% |
224,606
+18,000
| +9% | +$89.2K |
|
2218
Liberty Global Class C
LBTYK
$3.4B
| $1.08M | ﹤0.01% |
45,383
+165
| +0.4% | +$4.3K |
|
|
FEDU
2219
Four Seasons Education Depositary Shares Rep 10 Ordinary Shares
FEDU
$18.2M
| $1.08M | ﹤0.01% |
29,656
-4,631
| -14% | -$180K |
|
2220
AdvanSix
ASIX
$551M
| $1.08M | ﹤0.01% |
41,869
-6,550
| -14% | -$159K |
|
2221
Galicia Financial Group
GGAL
$7.9B
| $1.08M | ﹤0.01% |
82,828
-1,057,473
| -93% | -$24.9M |
|
2222
iShares Russell 2500 ETF
SMMD
$3.59B
| $1.08M | ﹤0.01% |
+24,180
| New | +$1.08M |
|
|
CMO
2223
DELISTED
Capstead Mortgage Corp.
CMO
| $1.08M | ﹤0.01% |
146,449
-16,098
| -10% | -$129K |
|
2224
Fate Therapeutics
FATE
$270M
| $1.06M | ﹤0.01% |
68,500
| – | – |
|
2225
Opko Health
OPK
$1.25B
| $1.06M | ﹤0.01% |
506,025
| – | – |
|
Similar funds
AllianceBernstein's Q3 2019 Portfolio in Review
As of Q3 2019, AllianceBernstein held 3,241 positions worth $161B, down 0.22% from $161B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
AllianceBernstein's Q3 2019 filing shows 100 new, 1,235 increased, 1,524 reduced and 89 closed positions. Its largest new stake was Dynatrace: 4,825,272 shares worth $90.1M. The largest sale was Walt Disney, an estimated $319M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- AllianceBernstein's largest Q3 2019 buy was Dynatrace: 4,825,272 shares worth $90.1M.
- AllianceBernstein added most to International Flavors & Fragrances in Q3 2019, an estimated $220M increase.
- AllianceBernstein's biggest Q3 2019 reduction was Walt Disney, cutting an estimated $319M.
- AllianceBernstein fully exited L3 Technologies, Inc. in Q3 2019, selling an estimated $122M.
- AllianceBernstein's ten largest holdings make up 18% of its $161B portfolio in Q3 2019.
- AllianceBernstein opened 100 new positions and closed 89 in Q3 2019.
- AllianceBernstein's portfolio value fell 0.22% quarter-over-quarter to $161B.
Based on AllianceBernstein's 13F filing for Q3 2019, filed 14 Nov 2019.